Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Iron, Hepcidin, and Death in Human AKI.

Leaf DE, Rajapurkar M, Lele SS, Mukhopadhyay B, Boerger EAS, Mc Causland FR, Eisenga MF, Singh K, Babitt JL, Kellum JA, Palevsky PM, Christov M, Waikar SS.

J Am Soc Nephrol. 2019 Feb 8. pii: ASN.2018100979. doi: 10.1681/ASN.2018100979. [Epub ahead of print]

PMID:
30737269
2.

Fibroblast Growth Factor 23 and Klotho in AKI.

Christov M, Neyra JA, Gupta S, Leaf DE.

Semin Nephrol. 2019 Jan;39(1):57-75. doi: 10.1016/j.semnephrol.2018.10.005. Review.

PMID:
30606408
3.

Dysregulated Mineral Metabolism in AKI.

Leaf DE, Christov M.

Semin Nephrol. 2019 Jan;39(1):41-56. doi: 10.1016/j.semnephrol.2018.10.004. Review.

PMID:
30606407
4.

Introduction: Cross-Talk Between the Kidneys and Remote Organ Systems in AKI.

Leaf DE.

Semin Nephrol. 2019 Jan;39(1):1-2. doi: 10.1016/j.semnephrol.2018.10.010. No abstract available.

PMID:
30606402
5.

De novo NAD+ biosynthetic impairment in acute kidney injury in humans.

Poyan Mehr A, Tran MT, Ralto KM, Leaf DE, Washco V, Messmer J, Lerner A, Kher A, Kim SH, Khoury CC, Herzig SJ, Trovato ME, Simon-Tillaux N, Lynch MR, Thadhani RI, Clish CB, Khabbaz KR, Rhee EP, Waikar SS, Berg AH, Parikh SM.

Nat Med. 2018 Sep;24(9):1351-1359. doi: 10.1038/s41591-018-0138-z. Epub 2018 Aug 20.

PMID:
30127395
6.

Risk Prediction Models for Acute Kidney Injury in Critically Ill Patients: Opus in Progressu.

Neyra JA, Leaf DE.

Nephron. 2018;140(2):99-104. doi: 10.1159/000490119. Epub 2018 May 31.

7.

Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation.

Postalcioglu M, Kim HT, Obut F, Yilmam OA, Yang J, Byun BC, Kupiec-Weglinski S, Soiffer R, Ritz J, Antin JH, Alyea E, Koreth J, Cutler C, Armand P, Paik JM, Leaf DE, Ho VT, Abdi R.

Biol Blood Marrow Transplant. 2018 Nov;24(11):2344-2353. doi: 10.1016/j.bbmt.2018.05.010. Epub 2018 May 11.

PMID:
29758394
8.

Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients.

Leaf DE, Siew ED, Eisenga MF, Singh K, Mc Causland FR, Srivastava A, Ikizler TA, Ware LB, Ginde AA, Kellum JA, Palevsky PM, Wolf M, Waikar SS.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):531-541. doi: 10.2215/CJN.10810917. Epub 2018 Mar 8.

PMID:
29519954
9.

Acute blood loss stimulates fibroblast growth factor 23 production.

Rabadi S, Udo I, Leaf DE, Waikar SS, Christov M.

Am J Physiol Renal Physiol. 2018 Jan 1;314(1):F132-F139. doi: 10.1152/ajprenal.00081.2017. Epub 2017 Sep 6.

10.

BPI Fold-Containing Family A Member 2/Parotid Secretory Protein Is an Early Biomarker of AKI.

Kota SK, Pernicone E, Leaf DE, Stillman IE, Waikar SS, Kota SB.

J Am Soc Nephrol. 2017 Dec;28(12):3473-3478. doi: 10.1681/ASN.2016121265. Epub 2017 Aug 3.

11.

C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients.

Eisenga MF, van Londen M, Leaf DE, Nolte IM, Navis G, Bakker SJL, de Borst MH, Gaillard CAJM.

J Am Soc Nephrol. 2017 Dec;28(12):3639-3646. doi: 10.1681/ASN.2016121350. Epub 2017 Aug 3.

12.

Autoimmune hemolytic anemia in a young man with acute hepatitis E infection.

Leaf RK, O'Brien KL, Leaf DE, Drews RE.

Am J Hematol. 2017 May;92(5):E77-E79. doi: 10.1002/ajh.24699. Epub 2017 Mar 22. No abstract available.

13.

Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series.

Cortazar FB, Leaf DE, Owens CT, Laliberte K, Pendergraft WF 3rd, Niles JL.

BMC Nephrol. 2017 Feb 1;18(1):44. doi: 10.1186/s12882-017-0459-z.

14.

Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness.

Leaf DE, Jacob KA, Srivastava A, Chen ME, Christov M, Jüppner H, Sabbisetti VS, Martin A, Wolf M, Waikar SS.

J Am Soc Nephrol. 2017 Jun;28(6):1877-1885. doi: 10.1681/ASN.2016080836. Epub 2016 Dec 27.

15.

Catalytic iron and acute kidney injury.

Leaf DE, Swinkels DW.

Am J Physiol Renal Physiol. 2016 Nov 1;311(5):F871-F876. doi: 10.1152/ajprenal.00388.2016. Epub 2016 Aug 17. Review.

16.

Length Polymorphisms in Heme Oxygenase-1 and AKI after Cardiac Surgery.

Leaf DE, Body SC, Muehlschlegel JD, McMahon GM, Lichtner P, Collard CD, Shernan SK, Fox AA, Waikar SS.

J Am Soc Nephrol. 2016 Nov;27(11):3291-3297. Epub 2016 Jun 2.

17.

End Points for Clinical Trials in Acute Kidney Injury.

Leaf DE, Waikar SS.

Am J Kidney Dis. 2017 Jan;69(1):108-116. doi: 10.1053/j.ajkd.2016.05.033. Epub 2016 Sep 3.

18.

A Genome-Wide Association Study to Identify Single-Nucleotide Polymorphisms for Acute Kidney Injury.

Zhao B, Lu Q, Cheng Y, Belcher JM, Siew ED, Leaf DE, Body SC, Fox AA, Waikar SS, Collard CD, Thiessen-Philbrook H, Ikizler TA, Ware LB, Edelstein CL, Garg AX, Choi M, Schaub JA, Zhao H, Lifton RP, Parikh CR; TRIBE-AKI Consortium * .

Am J Respir Crit Care Med. 2017 Feb 15;195(4):482-490. doi: 10.1164/rccm.201603-0518OC.

19.

Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.

Cortazar FB, Marrone KA, Troxell ML, Ralto KM, Hoenig MP, Brahmer JR, Le DT, Lipson EJ, Glezerman IG, Wolchok J, Cornell LD, Feldman P, Stokes MB, Zapata SA, Hodi FS, Ott PA, Yamashita M, Leaf DE.

Kidney Int. 2016 Sep;90(3):638-47. doi: 10.1016/j.kint.2016.04.008. Epub 2016 Jun 7.

20.

An electronic alert to decrease Kayexalate ordering.

Leaf DE, Cheng XS, Sanders JL, Mendu M, Schiff GD, Mount DB, Bazari H.

Ren Fail. 2016 Nov;38(10):1752-1754. doi: 10.1080/0886022X.2016.1185353. Epub 2016 May 17.

21.

Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery.

Leaf DE, Christov M, Jüppner H, Siew E, Ikizler TA, Bian A, Chen G, Sabbisetti VS, Bonventre JV, Cai X, Wolf M, Waikar SS.

Kidney Int. 2016 Apr;89(4):939-48. doi: 10.1016/j.kint.2015.12.035. Epub 2016 Feb 17.

22.

Excessive diagnostic testing in acute kidney injury.

Leaf DE, Srivastava A, Zeng X, McMahon GM, Croy HE, Mendu ML, Kachalia A, Waikar SS.

BMC Nephrol. 2016 Jan 15;17:9. doi: 10.1186/s12882-016-0224-8.

23.

Clinical predictors of diagnostic testing utility in the initial evaluation of chronic kidney disease.

Mendu ML, Lundquist A, Aizer AA, Leaf DE, Robinson E, Steele DJ, Waikar SS.

Nephrology (Carlton). 2016 Oct;21(10):851-9. doi: 10.1111/nep.12676.

24.

Intraoperative High-Dose Dexamethasone and Severe AKI after Cardiac Surgery.

Jacob KA, Leaf DE, Dieleman JM, van Dijk D, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, Diephuis JC, de Lange F, Boer C, Kluin J, Waikar SS; Dexamethasone for Cardiac Surgery (DECS) Study Group.

J Am Soc Nephrol. 2015 Dec;26(12):2947-51. doi: 10.1681/ASN.2014080840. Epub 2015 May 7.

25.

Cathelicidin antimicrobial protein, vitamin D, and risk of death in critically ill patients.

Leaf DE, Croy HE, Abrahams SJ, Raed A, Waikar SS.

Crit Care. 2015 Mar 10;19:80. doi: 10.1186/s13054-015-0812-1.

26.

The usefulness of diagnostic testing in the initial evaluation of chronic kidney disease.

Mendu ML, Lundquist A, Aizer AA, Leaf DE, Robinson E, Steele DJ, Waikar SS.

JAMA Intern Med. 2015 May;175(5):853-6. doi: 10.1001/jamainternmed.2015.17. No abstract available.

27.

Increased plasma catalytic iron in patients may mediate acute kidney injury and death following cardiac surgery.

Leaf DE, Rajapurkar M, Lele SS, Mukhopadhyay B, Rawn JD, Frendl G, Waikar SS.

Kidney Int. 2015 May;87(5):1046-54. doi: 10.1038/ki.2014.374. Epub 2015 Jan 7.

28.

Reply: active and native vitamin D in critical illness.

Leaf DE, Raed A, Donnino MW, Ginde AA, Waikar SS.

Am J Respir Crit Care Med. 2014 Nov 15;190(10):1194-6. doi: 10.1164/rccm.201408-1454LE. No abstract available.

PMID:
25398113
29.

Plasma catalytic iron, AKI, and death among critically ill patients.

Leaf DE, Rajapurkar M, Lele SS, Mukhopadhyay B, Waikar SS.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1849-56. doi: 10.2215/CJN.02840314. Epub 2014 Sep 4.

30.

Rosuvastatin for sepsis-associated ARDS.

Leaf DE, Waikar SS.

N Engl J Med. 2014 Sep 4;371(10):968. doi: 10.1056/NEJMc1408401. No abstract available.

PMID:
25184877
31.

Implementation of a CKD checklist for primary care providers.

Mendu ML, Schneider LI, Aizer AA, Singh K, Leaf DE, Lee TH, Waikar SS.

Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1526-35. doi: 10.2215/CJN.01660214. Epub 2014 Aug 18.

32.

Randomized controlled trial of calcitriol in severe sepsis.

Leaf DE, Raed A, Donnino MW, Ginde AA, Waikar SS.

Am J Respir Crit Care Med. 2014 Sep 1;190(5):533-41. doi: 10.1164/rccm.201405-0988OC.

33.

Patient visibility and ICU mortality: a conceptual replication.

Lu Y, Ossmann MM, Leaf DE, Factor PH.

HERD. 2014 Winter;7(2):92-103.

PMID:
24554358
34.

Colpocephaly in adults.

Esenwa CC, Leaf DE.

BMJ Case Rep. 2013 May 22;2013. pii: bcr2013009505. doi: 10.1136/bcr-2013-009505.

35.

Plasma FGF23 levels increase rapidly after acute kidney injury.

Christov M, Waikar SS, Pereira RC, Havasi A, Leaf DE, Goltzman D, Pajevic PD, Wolf M, Jüppner H.

Kidney Int. 2013 Oct;84(4):776-85. doi: 10.1038/ki.2013.150. Epub 2013 May 8.

36.

Chloride-liberal fluids and intracellular acidosis.

Leaf DE, McMahon GM, Seifter JL.

Kidney Int. 2013 May;83(5):971. doi: 10.1038/ki.2013.31. No abstract available.

37.

Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomes.

Leaf DE, Waikar SS, Wolf M, Cremers S, Bhan I, Stern L.

Clin Endocrinol (Oxf). 2013 Oct;79(4):491-8. doi: 10.1111/cen.12172. Epub 2013 Mar 26.

38.

Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma.

Leaf DE, Pereira RC, Bazari H, Jüppner H.

J Clin Endocrinol Metab. 2013 Mar;98(3):887-91. doi: 10.1210/jc.2012-3473. Epub 2013 Feb 7.

39.

A physiologic-based approach to the evaluation of a patient with hyperphosphatemia.

Leaf DE, Wolf M.

Am J Kidney Dis. 2013 Feb;61(2):330-6. doi: 10.1053/j.ajkd.2012.06.026. Epub 2012 Aug 30.

40.

FGF-23 levels in patients with AKI and risk of adverse outcomes.

Leaf DE, Wolf M, Waikar SS, Chase H, Christov M, Cremers S, Stern L.

Clin J Am Soc Nephrol. 2012 Aug;7(8):1217-23. doi: 10.2215/CJN.00550112. Epub 2012 Jun 14.

41.

Laxative abuse, eating disorders, and kidney stones: a case report and review of the literature.

Leaf DE, Bukberg PR, Goldfarb DS.

Am J Kidney Dis. 2012 Aug;60(2):295-8. doi: 10.1053/j.ajkd.2012.02.337. Epub 2012 May 4. Review.

PMID:
22560842
42.

Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers.

Leaf DE, Korets R, Taylor EN, Tang J, Asplin JR, Goldfarb DS, Gupta M, Curhan GC.

Clin J Am Soc Nephrol. 2012 May;7(5):829-34. doi: 10.2215/CJN.11331111. Epub 2012 Mar 15.

43.

Calcium kidney stones.

Leaf DE.

N Engl J Med. 2010 Dec 16;363(25):2470; author reply 2471. doi: 10.1056/NEJMc1011349. No abstract available.

PMID:
21158674
44.

A severe case of cefoxitin-induced immune hemolytic anemia.

Leaf DE, Langer NB, Markowski M, Garratty G, Diuguid DL.

Acta Haematol. 2010;124(4):197-9. doi: 10.1159/000320169. Epub 2010 Nov 2.

PMID:
21042010
45.

Glomerular disease: why is there a dearth of high quality clinical trials?

Leaf DE, Appel GB, Radhakrishnan J.

Kidney Int. 2010 Aug;78(4):337-42. doi: 10.1038/ki.2010.156. Epub 2010 Jun 2. Review.

46.

Computer scoring of the Levels of Emotional Awareness Scale.

Barchard KA, Bajgar J, Leaf DE, Lane RD.

Behav Res Methods. 2010 May;42(2):586-95. doi: 10.3758/BRM.42.2.586.

PMID:
20479190
47.

Relationship between ICU design and mortality.

Leaf DE, Homel P, Factor PH.

Chest. 2010 May;137(5):1022-7. doi: 10.1378/chest.09-1458. Epub 2010 Jan 15.

PMID:
20081100
48.

Elevated FGF-23 in a patient with rhabdomyolysis-induced acute kidney injury.

Leaf DE, Wolf M, Stern L.

Nephrol Dial Transplant. 2010 Apr;25(4):1335-7. doi: 10.1093/ndt/gfp682. Epub 2009 Dec 27.

PMID:
20037176
49.

SOMOSAT: Utility of a web-based self-assessment tool in undergraduate medical education.

Leaf DE, Leo J, Smith PR, Yee H, Stern A, Rosenthal PB, Cahill-Gallant EB, Pillinger MH.

Med Teach. 2009 May;31(5):e211-9.

PMID:
19811126
50.

Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia.

Leaf DE, Goldfarb DS.

Kidney Int. 2009 Jan;75(1):15-24. doi: 10.1038/ki.2008.414. Epub 2008 Aug 27. Review.

Supplemental Content

Support Center